Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Cardiology

• Publication date

  1999-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(99)00129-0PMID 10335768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.

  1997cited by this paper
• L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules.

  1997cited by this paper
• Nitric oxide activity in the atherosclerotic human coronary circulation.

  1997cited by this paper
• Aging-associated endothelial dysfunction in humans is reversed by L-arginine.

  1996cited by this paper
• Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*)

  1995cited by this paper
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

  1995cited by this paper
• Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

  1995cited by this paper
• Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure.

  1995cited by this paper
• Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

  1995cited by this paper
• Monitoring the quality of life in patients with coronary artery disease.

  1994cited by this paper
• Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.

  1994cited by this paper
• Inhibition by nitric oxide‐donors of human polymorphonuclear leucocyte functions

  1993cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine.

  1992cited by this paper
• Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries.

  1992cited by this paper
• L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

  1992cited by this paper
• Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine.

  1991cited by this paper
• Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

  1990cited by this paper
• Concentrations of Immunoreactive Human Tumor Necrosis Factor Alpha Produced by Human Mononuclear Cells In Vitro

  1988cited by this paper
• Development and use of a radioimmunoassay for human interleukin-1 beta.

  1987cited by this paper

• Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF2α in patients with myocardial infarction in the randomized RIMINI-Trial

  2019cites this paper
• Protective Effects of Functional Amino Acids on Apoptosis, Inflammatory Response, and Pulmonary Fibrosis in Lipopolysaccharide-Challenged Mice.

  2019cites this paper
• Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis

  2018cites this paper
• l-Arginine treatment improves angiogenic response and reduces matrix metalloproteinase activity in chronic heart failure patients with coronary artery disease

  2018cites this paper
• Beneficial Impact of Cod Protein, l-Arginine, and Other Amino Acids on Insulin Sensitivity

  2017cites this paper
• l-Arginine and Cardiovascular Disease

  2017cites this paper
• Benefits of Nut Consumption on Insulin Resistance and Cardiovascular Risk Factors: Multiple Potential Mechanisms of Actions

  2017cites this paper
• Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease

  2016cites this paper
• Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: A double-blind, randomized, clinical trial

  2016cites this paper
• The eNOS T786C mutation, Prinzmetal's Variant Angina, and amelioration of angina by l-arginine in 59 patients with intractable angina despite calcium channel blocker–nitrate therapy

  2015cites this paper
• Medical Therapy for Chronic Refractory Angina

  2012cites this paper
• OralL-argininesupplementationinpatients withmildarterialhypertensionanditseffecton plasmalevelofasymmetricdimethylarginine, L-citrulline,L-arginineandantioxidantstatus

  2012cites this paper
• Alternative therapies for chronic refractory coronary artery disease

  2012cites this paper
• Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status.

  2012cites this paper
• Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial.

  2011cites this paper
• The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure.

  2008cites this paper
• Mechanisms of Disease: L-arginine in coronary atherosclerosis—a clinical perspective

  2007cites this paper
• A practical guide for clinicians

  2007cites this paper
• Coronary Artery Disease

  2007cites this paper
• Supplemental Conditionally Essential Nutrients in Cardiovascular Disease Therapy

  2006cites this paper
• L-Arginine supplementation in sepsis: beneficial or harmful?

  2006cites this paper
• Quantifying the L-arginine paradox in vivo.

  2006cites this paper
• Nitric oxide and atherosclerosis: an update.

  2006cites this paper
• Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

  2005cites this paper
• Efeitos da suplementação de L-arginina e do exercício em cicloergômetro sobre a função endotelial e estresse oxidativo em indivíduos com diabetes tipo 1

  2005cites this paper
• Therapeutic Uses of Amino Acids

  2005cites this paper
• L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease.

  2005cites this paper
• New trends in anti-atherosclerotic agents.

  2005cites this paper
• L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.

  2005cites this paper
• L-arginine and cardiovascular system.

  2005cites this paper
• Arginine Metabolism : Enzymology , Nutrition , and Clinical Significance Arginine and Endothelial and Vascular Health 1 , 2

  2004cites this paper
• Systematic review of statistical methods used to analyze Seattle Angina Questionnaire scores.

  2004cites this paper
• A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets.

  2004cites this paper
• Nutrachemicals in the Prevention and Treatment of Cardiovascular Disease

  2004cites this paper
• Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

  2004cites this paper
• Arginine and endothelial and vascular health.

  2004cites this paper
• L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty.

  2004cites this paper
• Nitric oxide-releasing drugs.

  2003cites this paper
• Nutraceuticals: a pharmaceutical viewpoint: I

  2002cites this paper
• L-Arginine in cardiovascular disease: dream or reality?

  2002cites this paper
• Arginine: Clinical potential of a semi-essential amino acid..

  2002cites this paper
• Vascular effects of dietary L-arginine supplementation.

  2002influential citation
• Oral L-arginine (and other active ingredients) for ischemic heart disease?.

  2002cites this paper
• Dietary modulation of endothelial function: implications for cardiovascular disease.

  2001cites this paper
• Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia.

  2001cites this paper
• Nitric oxide and atherosclerosis.

  2001cites this paper
• l ‐Arginine for the prevention and treatment of coronary artery disease

  2001cites this paper
• Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.

  2001cites this paper
• Nutraceuticals: vitamins and other nutrients in coronary heart disease

  2001cites this paper
• Nitric Oxide and Atherosclerotic Lesion Progression: An Overview

  2001cites this paper
• Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.

  1999cites this paper